Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, shares four critical steps for successful healthcare collaborations.

In the second quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

The laboratory test catalog is no longer just a reference list — it’s a strategic asset. By expanding its content, laboratories can improve satisfaction and experience.

In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Today's Highlights Include: COVID-19 deaths remain low compared to previous winters, FDA authorizing first at-home combo flu/Covid test, and Rochester public schools evaluating mental health needs and services throughout the district.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Beshoi Nashed, a visiting medical student from the Medical University of the Americas in Saint Kitts and Nevis, about his personal perspective on life that has helped him succeed where many others are challenged.

This page shows updates posted to Mayo Clinic Labs during the month of February.

As a senior principal developer for the brand-new Process Innovation Through Automation Laboratory, Brian Dukek helps labs throughout the Department of Laboratory Medicine and Pathology evaluate new automation tools and streamline automation workflows.

Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC, explain how Mayo Clinic Laboratories' whole genome sequencing provides comprehensive information for rapid diagnosis of hereditary disorders.

This week's Research Roundup features: Laboratory and metabolic investigations.

Today's Highlights Include: Ozempic running low for diabetes patients as weight-loss use surges, and Rochester public schools gets $1.9M for mental health scholarships.

Host Bobbi Pritt, M.D., is joined by Robin Patel, M.D., co-director of the Clinical Bacteriology Laboratory at Mayo Clinic and director of the Mayo Clinic Infectious Diseases Research Laboratory, for a discussion on the rising cases and reports of group A streptococcus and antibiotic resistant gonorrhea across the United States.

Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor analysis compared with other test methods.

This week's Research Roundup features: Predicting amyloid PET and tau PET stages with plasma biomarkers.

A major winter storm will move across the West Coast and Upper Midwest through Thursday, Feb. 23. We are monitoring and tracking the situation with our logistics partners to minimize challenges.